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CORE COMPETENCIES FOR 
THE PREVENTION AND MANAGEMENT 
OF PRESCRIPTION DRUG MISUSE 
 
 
Working Group Background:   
 
In an effort to prepare the next generation of physicians with the necessary tools to curb the 
nation’s current opioid epidemic, the Baker-Polito Administration, the Massachusetts Medical Society, 
and the deans of the Commonwealth’s four medical schools – Boston University School of Medicine; 
Harvard Medical School; Tufts School of Medicine; and the University of Massachusetts Medical 
School – have partnered in enhancing current medical school core competencies. This first-in-the-nation 
partnership has resulted in the establishment of cross-institutional core competencies for the prevention 
and management of prescription drug misuse that will reach the approximately 3,000 enrolled medical 
students across the Commonwealth of Massachusetts. 
 
 This collaboration and set of cross-institutional core competencies will provide medical students 
with enhanced training in primary, secondary, and tertiary prevention strategies regarding prescription 
drug misuse, representing an innovative and forward-thinking contribution to a multi-faceted strategy to 
curb the opioid epidemic. The Commonwealth of Massachusetts is again setting a new standard – this 
time by providing medical students with a strong foundation in prevention, identifying substance use 
disorders, and referring patients to appropriate treatment. With this enhanced educational foundation, 
Massachusetts’ medical students will be better prepared to enter residency training and to provide 
excellent patient care as our future physicians. 
 
Core Competencies Overview:  
 
The Governor’s Working Group is pleased to outline the following cross-institutional consensus 
document regarding a set of measureable core competencies for the prevention and management of 
prescription drug misuse. Working Group membership, representing the Department of Public Health, 
the Massachusetts Medical Society, and all four Massachusetts medical schools – Boston University 
School of Medicine; Harvard Medical School; Tufts School of Medicine; and the University of 
Massachusetts Medical School – convened over a series of four working meetings, advancing 
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recommendations that responded to a literature review, including over twenty-five peer-reviewed journal 
articles and current standards.  
 
The following recommendations for the core competency domains will be adopted by all four 
schools for integration into the medical school training of all Massachusetts medical students. Each 
school will establish appropriate curricular interventions and innovations to ensure that the stated 
competencies are being addressed for all students, allowing schools to tailor these competencies to their 
own curriculum development.  
 
To this end, the four schools have agreed in principle to develop and implement substantive 
assessment of these competencies in order to evaluate students for baseline and post-implementation 
measurements. The Working Group recognizes opportunities to link these skills to emerging trends in 
competency development (e.g. linkage to the AAMC- and ACGME-endorsed Entrustable Professional 
Activities or “EPAs” model). Further, that the best evidence in medical education supports performance-
based evaluation as a key component of competency-based curricula, utilizing clinical settings or 
simulation- and/or patient-based assessments using standardized patients and technology-enhanced 
simulation. These assessments represent the gold standard for objective competency evaluation of 
medical students and residents. 
 
Preamble:  
 
 The following cross-institutional core competencies are framed from the perspective of an 
encounter with a patient who typically presents with pain and/or other medical symptoms for which a 
prescription medication with the potential for misuse may be indicated. The goal of the stated core 
competencies is to support future physicians, over the course of their medical education, with both skills 
and a foundational knowledge in the prevention of prescription drug misuse. These competencies set 
clear baseline standards for primary (preventing prescription drug misuse), secondary (treating patients 
at-risk for substance use disorders), and tertiary (managing substance use disorders as a chronic disease) 
prevention skills and knowledge in the areas of screening, evaluation, treatment planning, and 
supportive recovery. While these competencies have been stratified into prevention domains, the 
following competencies are not intended to be wholly exclusive to any one prevention level; rather, this 
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document enlists skills and knowledge which should be broadly applied to enhance a future medical 
professional’s ability to prevent and manage prescription drug misuse. 
 
These core competencies are designed to serve as a vital bridge between medical student 
education and medical residency training, ensuring that future generations of prescribers are equipped 
with essential skills for high quality medical practice and safe prescribing. These concepts both 
encourage and demand a physicians’ understanding of the importance of both team- and system-based 
care provision, ensuring the holistic treatment of substance use disorders as a chronic disease. The four 
Massachusetts medical schools universally recognize these competencies as integral to the abilities of all 
medical students, residents, and practicing medical professionals to safely and competently prescribe 
prescription drugs, and to successfully prevent, identify, and treat substance use disorders.
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CORE COMPETENCIES FOR  
THE PREVENTION AND MANAGEMENT  
OF PRESCRIPTION DRUG MISUSE  
 
In the appropriate setting, using recommended and evidence-based methodologies, the graduating medical 
student should demonstrate the independent ability and/or knowledge to: 
 
 Primary Prevention Domain – Preventing Prescription Drug Misuse: Screening, Evaluation, and 
Prevention 
 
1. Evaluate a patient’s pain using age, gender, and culturally appropriate evidence-based 
methodologies. 
 
2. Evaluate a patient’s risk for substance use disorders by utilizing age, gender, and culturally 
appropriate evidence-based communication skills and assessment methodologies, supplemented 
with relevant available patient information, including but not limited to health records, family 
history, prescription dispensing records (e.g. the Prescription Drug Monitoring Program or “PMP”), 
drug urine screenings, and screenings for commonly co-occurring psychiatric disorders (especially 
depression, anxiety disorders, and PTSD). 
 
3. Identify and describe potential pharmacological and non-pharmacological treatment options 
including opioid and non-opioid pharmacological treatments for acute and chronic pain 
management, along with patient communication and education regarding the risks and benefits 
associated with each of these available treatment options. 
 
 Secondary Prevention Domain – Treating Patients At-Risk for Substance Use Disorders: Engage 
Patients in Safe, Informed, and Patient-Centered Treatment Planning 
 
4. Describe substance use disorder treatment options, including medication-assisted treatment, as well 
as demonstrate the ability to appropriately refer patients to addiction medicine specialists and 
treatment programs for both relapse prevention and co-occurring psychiatric disorders. 
 
5. Prepare evidence-based and patient-centered pain management and substance use disorder 
treatment plans for patients with acute and chronic pain with special attention to safe prescribing 
and recognizing patients displaying signs of aberrant prescription use behaviors.  
 
6. Demonstrate the foundational skills in patient-centered counselling and behavior change in the 
context of a patient encounter, consistent with evidence-based techniques. 
 
 Tertiary Prevention Domain - Managing Substance Use Disorders as a Chronic Disease: Eliminate 
Stigma and Build Awareness of Social Determinants  
 
7. Recognize the risk factors for, and signs of, opioid overdose and demonstrate the correct use of 
naloxone rescue. 
 
8. Recognize substance use disorders as a chronic disease by effectively applying a chronic disease 
model in the ongoing assessment and management of the patient. 
 
9. Recognize their own and societal stigmatization and biases against individuals with substance use 
disorders and associated evidence-based medication-assisted treatment. 
 
10. Identify and incorporate relevant data regarding social determinants of health into treatment 
planning for substance use disorders.
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Recommended Evidence-Based Methodologies for the  
Prevention and Management of Prescription Drug Misuse: 
 
In the appropriate setting, and across all prevention areas, it is recommended that the graduating medical 
student have operational knowledge of: 
 
 Diagnosis-Intractability-Risk-Efficacy (DIRE) 
 
 Motivational Interviewing (MI) 
 
 Opioid Risk Tool (ORT) 
 
 Safe Prescribing “Universal Precautions” 
 
 Screening, Brief Intervention, and Referral to Treatment (SBIRT) 
 
 Screener and Opioid Assessment for Patients with Pain (SOAPP) 
 
 Screening Tool for Addiction Risk (STAR) 
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